Get to know our clinical trials

Phase III trial to evaluate the efficacy, safety and tolerability of Baxdrostat combined with Dapagliflozin, compared to Dapagliflozin monotherapy, on renal outcomes and cardiovascular mortality in patients with CKD

THE AIM OF THIS STUDY IS TO LEARN MORE ABOUT THE BENEFITS AND SAFETY OF THE TREATMENT OF AN INVESTIGATIONAL DRUG CALLED BAXDROSTAT IN COMBINATION WITH DAPAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH CKD AND HIGH BLOOD PRESSURE. WE ALSO WANT TO BETTER UNDERSTAND CKD AND ITS ACCOMPANYING HEALTH PROBLEMS.

Imagen de la Dra. Nuria García Fernández, especialista en Nefrología de la Clínica Universidad de Navarra. La Dra. García se dedica preferencialmente a la enfermedad renal crónica avanzada, al paciente con diabetes y enfermedad renal, y la hemodiálisis.
Dr. Nuria García Fernández [SP] Curriculum
Director Nephrology department
Navarre headquarters
Madrid headquarters
Status
In recruitment
headquarters
Pamplona

Technical Summary

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION